返回
Nemaura Medical Inc（NMRD）價格
NMRD 股價走勢圖
NMRD 收益
Nemaura Medical Inc
$0
0%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$0
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$0.0001
開盤價
$0.0002
當日範圍
$0.0001 - $0.0002
52週區間
$0.0001 - $0.0002
交易量
500
平均成交量
3.6K
每股盈餘 (TTM)
-0.38
股息收益率
--
市值
$4.0K
什麼是 NMRD？
Nemaura Medical, Inc. operates as a holding company. The company is headquartered in Manhattan, New York and currently employs 36 full-time employees. The company went IPO on 2014-11-04. The sugarBEAT device is a non-invasive, wireless device for use by persons with Type I and Type II diabetes and may also be used to screen pre-diabetic patients and support obesity and weight-loss programs. The sugarBEAT device extracts analytes, such as glucose, to the surface of the skin in a non-invasive manner where it is measured using sensors and interpreted using an algorithm. The Company’s applications of its technology include glucose monitoring, temperature monitoring, lactate monitoring, alcohol monitoring, and substance abuse monitoring. Its platform uses precision microsystems-based technology.